Alternatives to Emmecell
Emmecell is a Biotechnology tool: developing magnetic cell delivery platform for advanced therapies. Here are the 52 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Emmecell
CRISPR TherapeuticsNot ratedBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Pixelgen TechnologiesNot ratedA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Epicrispr BiotechnologiesNot ratedEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
FreenomeNot ratedFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
LifeMine Therapeutics Inc.Not ratedClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Spark TherapeuticsNot ratedA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
ImmunoScapeNot ratedDeveloping novel immunotherapies and diagnostics for cancer.
KaliVir Immunotherapeutics, Inc.5.0 out of 5 (1)Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
Janux TherapeuticsNot ratedA clinical-stage biopharmaceutical company developing novel immunotherapies.
Verve TherapeuticsNot ratedDeveloping gene editing therapies to lower cholesterol.
Anagram TherapeuticsNot ratedClinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.
Verdiva Bio3.0 out of 5 (1)Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
CellaresNot ratedThe first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.
Showing the next 20 closest matches. See the rest on the Emmecell profile.
Sponsored rows are paid and labelled. Advertise on this page
